The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions/Experiment 1

From BugSigDB


Reviewed Marked as Reviewed by Fatima Zohra on 2021/02/09

Curated date: 2021/01/10

Curator: WikiWorks

Revision editor(s): WikiWorks

Subjects

Location of subjects
United States of America
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Uterine cervix Canalis cervicis uteri,Caudal segment of uterus,Cervical canal,Cervical canal of uterus,Cervix,Cervix of uterus,Cervix uteri,Neck of uterus,Uterine cervix,uterine cervix
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Cervical glandular intraepithelial neoplasia Cervical glandular intraepithelial neoplasia,cervical glandular intraepithelial neoplasia
Group 0 name Corresponds to the control (unexposed) group for case-control studies
CIN regression
Group 1 name Corresponds to the case (exposed) group for case-control studies
CIN non-regression
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
histology proven CIN2, no regression after 12 months
Group 0 sample size Number of subjects in the control (unexposed) group
42
Group 1 sample size Number of subjects in the case (exposed) group
45

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V1-V2
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2


Signature 1

Reviewed Marked as Reviewed by Fatima Zohra on 2021/02/09

Curated date: 2021/01/10

Curator: Cynthia Anderson

Revision editor(s): WikiWorks

Source: Figure 5

Description: LEfSe analysis identified baseline vaginal microbiota biomarkers associated with clinical outcomes at 12 months follow-up

Abundance in Group 1: increased abundance in CIN non-regression

NCBI Quality ControlLinks
Hoylesella timonensis
Negativicutes
Selenomonadales
Coriobacteriales
Eubacteriales
Atopobium
Fannyhessea vaginae
Coriobacteriaceae
Fusobacteriota
Sneathia
Leptotrichiaceae
Veillonellaceae
Megasphaera
Fusobacteriia
Fusobacteriales
Parvimonas
Clostridia
Lachnospiraceae
Prevotella
Bacteroidota
Bacteroidia
Prevotellaceae
Bacteroidales
Actinomycetes

Revision editor(s): WikiWorks

Signature 2

Reviewed Marked as Reviewed by Fatima Zohra on 2021/02/09

Curated date: 2021/01/10

Curator: Cynthia Anderson

Revision editor(s): WikiWorks

Source: Figure 5

Description: LEfSe analysis identified baseline vaginal microbiota biomarkers associated with clinical outcomes at 12 months follow-up

Abundance in Group 1: decreased abundance in CIN non-regression

NCBI Quality ControlLinks
Lactobacillales
Bacilli
Lactobacillaceae
Lactobacillus
Bacillota

Revision editor(s): WikiWorks